ATE142489T1 - Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen - Google Patents
Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungenInfo
- Publication number
- ATE142489T1 ATE142489T1 AT91910048T AT91910048T ATE142489T1 AT E142489 T1 ATE142489 T1 AT E142489T1 AT 91910048 T AT91910048 T AT 91910048T AT 91910048 T AT91910048 T AT 91910048T AT E142489 T1 ATE142489 T1 AT E142489T1
- Authority
- AT
- Austria
- Prior art keywords
- prevention
- treatment
- pharmaceutically acceptable
- glucaric acid
- cellular hyperproliferation
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title abstract 4
- 208000035150 Hypercholesterolemia Diseases 0.000 title 1
- 230000004663 cell proliferation Effects 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 abstract 4
- 230000001413 cellular effect Effects 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- DSLZVSRJTYRBFB-LLEIAEIESA-L D-glucarate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O DSLZVSRJTYRBFB-LLEIAEIESA-L 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 229940029985 mineral supplement Drugs 0.000 abstract 1
- 235000020786 mineral supplement Nutrition 0.000 abstract 1
- 235000020772 multivitamin supplement Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52538490A | 1990-05-16 | 1990-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE142489T1 true ATE142489T1 (de) | 1996-09-15 |
Family
ID=24093031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91910048T ATE142489T1 (de) | 1990-05-16 | 1991-05-15 | Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US5364644A (de) |
| EP (2) | EP0730862A1 (de) |
| JP (1) | JPH06504259A (de) |
| AT (1) | ATE142489T1 (de) |
| CA (1) | CA2080818A1 (de) |
| DE (1) | DE69122099T2 (de) |
| WO (1) | WO1991018593A1 (de) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0730862A1 (de) * | 1990-05-16 | 1996-09-11 | Zbigniew Walaszek | Glucarsäure enthaltende Formulierung zur Prävention und Behandlung gutartiger Zellhyperproliferation und Diätergänzung |
| FR2693876A1 (fr) * | 1992-07-24 | 1994-01-28 | Vani | Complément nutritif à base de micronutriments. |
| BE1006217A6 (fr) * | 1992-09-10 | 1994-06-14 | Steils Anne Epouse Gerome | Boisson lactee enrichie de nutriments. |
| CA2089607C (en) * | 1992-11-05 | 1997-11-04 | Ranjit K. Chandra | Nutritional supplement for the elderly |
| US5891459A (en) * | 1993-06-11 | 1999-04-06 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
| WO1995035038A1 (de) * | 1994-06-20 | 1995-12-28 | Peter Singer | Diätetisches lebensmittel und dessen verwendung |
| US5626884A (en) * | 1995-08-18 | 1997-05-06 | Lockett; Curtis G. | Treatment of sickle cell disease |
| AU724620B2 (en) * | 1996-01-16 | 2000-09-28 | Sokol, Ronald J Dr. | Use of antioxidant agents to treat cholestatic liver disease |
| AU727225B2 (en) * | 1997-01-27 | 2000-12-07 | Takara Bio Inc. | Tetrahydrofurans |
| EP0969743B1 (de) | 1997-03-20 | 2004-09-15 | Coventry Group, Ltd. | Nährungsergänzungsmittel für kardiovasküläre gesundheit |
| ITFI970184A1 (it) * | 1997-07-30 | 1999-01-30 | Menarini Farma Ind | Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico |
| US7371415B1 (en) | 1998-04-03 | 2008-05-13 | The Daily Wellness Company | Method and composition for improving sexual fitness |
| AU3221599A (en) * | 1998-04-03 | 1999-10-25 | Daily Wellness Company, The | Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation |
| GB2337933A (en) * | 1998-06-04 | 1999-12-08 | Stephen Bloor | Treating or prophylaxis of smoking related diseases |
| US6245360B1 (en) * | 1998-06-26 | 2001-06-12 | John S. Markowitz | Nutritional supplement |
| US6103733A (en) * | 1998-09-09 | 2000-08-15 | Bachmann; Kenneth A. | Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes |
| EP1175158A1 (de) * | 1999-05-07 | 2002-01-30 | Trustees Of Tufts College | Immun-stimulierender nahrungszusatz, und methode für seine verwendung |
| EP1189623B1 (de) * | 1999-06-05 | 2007-03-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methode und zusammensetzung zur inhibierung von kardiovaskulärer zellproliferation |
| HUP0300669A2 (en) * | 1999-08-17 | 2003-11-28 | Jaroslav Hanzel | Composition for preventing iodine deficiency |
| GB0016452D0 (en) * | 2000-07-04 | 2000-08-23 | Kilgowan Limited | Vitamin K and essential fatty acids |
| ES2168226B1 (es) * | 2000-11-27 | 2003-09-16 | Recuperat Ion Electrolitos S L | Composicion que comprende sodio, potasio, calcio y magnesio. |
| US6989164B2 (en) | 2000-12-22 | 2006-01-24 | The Daily Wellness Company | Method and composition for improving male fertility health |
| US6497885B2 (en) * | 2000-12-22 | 2002-12-24 | The Daily Wellness Company | Method and composition for improving fertility health in female and male animals and humans |
| US6596762B2 (en) | 2001-05-17 | 2003-07-22 | The Regents Of The University Of Colorado | Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis |
| US6849613B2 (en) * | 2001-08-29 | 2005-02-01 | Kedar N. Prasad | Multiple antioxidant micronutrients |
| US6562378B1 (en) * | 2002-08-16 | 2003-05-13 | Tsar Health Private Ltd. | Nutritional supplement for adolescents |
| US6565891B1 (en) * | 2002-08-23 | 2003-05-20 | Tsar Health Private Ltd. | Nutritional supplement for children |
| US20080020035A1 (en) * | 2002-08-28 | 2008-01-24 | Kedar Prasad | Micronutrient formulations and related methods of manufacture |
| US7635469B2 (en) * | 2002-08-28 | 2009-12-22 | Premier Micronutrient Corporation | Micronutrient formulations for hearing health |
| JP2007526316A (ja) * | 2004-03-01 | 2007-09-13 | ルーメン セラピューティックス リミテッド ライアビリティ カンパニー | 疾患を処置するための組成物および方法 |
| GB2416981A (en) * | 2004-08-13 | 2006-02-15 | Nutraceuticals Ltd | Premixes, flour enriched with same, mineral supplemented foodstuffs and methods of manufacture therefore. |
| US7628984B2 (en) * | 2005-02-17 | 2009-12-08 | Premier Micronutrient Corporation | Micronutrient formulations for pulmonary and heart health |
| US20090250653A1 (en) | 2006-08-07 | 2009-10-08 | Kiely Donald E | Hydroxycarboxylic Acids and Salts |
| US7692041B2 (en) | 2006-08-07 | 2010-04-06 | The University Of Montana | Method of oxidation using nitric acid |
| DE102006040456A1 (de) * | 2006-08-25 | 2008-02-28 | Constantin Nies | Verzehrbare flächige Darreichungsform von Nahrungsergänzungsmitteln und/oder Arzneiwirkstoffen zur Ergänzung von fertigen oder halbfertigen Nahrungsmitteln |
| US7605145B2 (en) * | 2006-11-20 | 2009-10-20 | Premier Micronutrient Corporation | Micronutrient formulations for treatment of diabetes mellitus |
| CN104224835A (zh) * | 2007-10-25 | 2014-12-24 | 营养株式会社 | 用于降低血中的糖、丙二醛修饰ldl、同型半胱氨酸和/或c反应蛋白的组合物 |
| AU2008322438B2 (en) | 2007-11-15 | 2014-06-19 | The University Of Montana | Hydroxypolyamide gel forming agents |
| WO2012065001A1 (en) | 2010-11-11 | 2012-05-18 | Rivertop Renewables | Corrosion inhibiting composition |
| RU2609417C2 (ru) | 2011-04-21 | 2017-02-01 | Ривертоп Реньюэблс, Инк. | Связывающая кальций композиция |
| EP2925826A1 (de) | 2012-11-28 | 2015-10-07 | Rivertop Renewables | Korrosionshemmende und gefrierpunktsenkende zusammensetzungen |
| US9670124B2 (en) | 2013-03-13 | 2017-06-06 | Rivertop Renewables, Inc. | Nitric acid oxidation process |
| US9346736B2 (en) | 2013-03-13 | 2016-05-24 | Rivertop Renewables, Inc. | Oxidation process |
| WO2014159694A1 (en) | 2013-03-13 | 2014-10-02 | Rivertop Renewables, Inc. | Improved nitric acid oxidation processes |
| US10499682B2 (en) | 2014-08-25 | 2019-12-10 | New Age Beverage Corporation | Micronutrient formulation in electronic cigarettes |
| US20220408778A1 (en) * | 2019-09-05 | 2022-12-29 | Societe Des Produits Nestle S.A. | Food compositions for lactating women |
| EP4025074A1 (de) * | 2019-09-05 | 2022-07-13 | Société des Produits Nestlé S.A. | Lebensmittelzusammensetzungen für stillende frauen |
| US11278520B2 (en) * | 2020-03-31 | 2022-03-22 | Sabine Hazan | Method of preventing COVID-19 infection |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1066885A (en) * | 1964-07-29 | 1967-04-26 | Zh Tokyo Seikagaku Kenkyukai | Therapeutic agent and compositions having the inhibitory action for ª‰-glucuronidase and method of inhibiting ª‰-glucuronidase |
| US3697287A (en) * | 1969-01-28 | 1972-10-10 | Morton Norwich Products Inc | Amino acid food composition |
| FR2370471A1 (fr) * | 1976-11-13 | 1978-06-09 | Kohler Valentin | Agents a base d'acide glucarique possedant une activite pharmaceutique et/ou anti-microbienne |
| DE2651947A1 (de) * | 1976-11-13 | 1978-05-18 | Koehler Valentin | Mittel mit pharmazeutischer und/oder antimikrobieller wirksamkeit |
| US4751085A (en) * | 1984-08-29 | 1988-06-14 | Gaull Gerald E | Human nutritional compositions containing taurine and vitamins and/or minerals |
| US4845123A (en) * | 1985-08-05 | 1989-07-04 | The Ohio State University | Reduction in vivo of the inappropriate levels of endogenous and environmental-derived compounds by sustained-release inhibitors of β-g |
| US4740373A (en) * | 1986-05-27 | 1988-04-26 | Usv Pharmaceutical Corporation | Stabilization of multivitamin/trace elements formulations |
| US5008291A (en) * | 1987-08-26 | 1991-04-16 | Ohio State University Research Foundation | Method and composition for achieving chemotherapeutic activity |
| US5010107A (en) * | 1987-08-26 | 1991-04-23 | Ohio State University Research Foundation | Method and composition for achieving anticarcinogenic activity |
| US4997852A (en) * | 1987-08-26 | 1991-03-05 | Ohio State University Research Foundation | Method and composition for achieving cancer chemopreventive and chemotherapeutic activity |
| EP0730862A1 (de) * | 1990-05-16 | 1996-09-11 | Zbigniew Walaszek | Glucarsäure enthaltende Formulierung zur Prävention und Behandlung gutartiger Zellhyperproliferation und Diätergänzung |
-
1991
- 1991-05-15 EP EP96200094A patent/EP0730862A1/de not_active Withdrawn
- 1991-05-15 AT AT91910048T patent/ATE142489T1/de active
- 1991-05-15 WO PCT/US1991/003378 patent/WO1991018593A1/en active IP Right Grant
- 1991-05-15 DE DE69122099T patent/DE69122099T2/de not_active Expired - Fee Related
- 1991-05-15 CA CA002080818A patent/CA2080818A1/en not_active Abandoned
- 1991-05-15 JP JP3509441A patent/JPH06504259A/ja active Pending
- 1991-05-15 EP EP91910048A patent/EP0528950B1/de not_active Expired - Lifetime
-
1993
- 1993-01-28 US US08/012,145 patent/US5364644A/en not_active Expired - Lifetime
-
1994
- 1994-10-04 US US08/317,790 patent/US5561160A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06504259A (ja) | 1994-05-19 |
| EP0528950B1 (de) | 1996-09-11 |
| US5561160A (en) | 1996-10-01 |
| WO1991018593A1 (en) | 1991-12-12 |
| DE69122099D1 (de) | 1996-10-17 |
| EP0528950A1 (de) | 1993-03-03 |
| EP0528950A4 (en) | 1993-03-24 |
| US5364644A (en) | 1994-11-15 |
| DE69122099T2 (de) | 1997-04-17 |
| CA2080818A1 (en) | 1991-11-17 |
| EP0730862A1 (de) | 1996-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE142489T1 (de) | Zusammensetzung und verfahren zur prävention und behandlung von hypercholesterinämie und zellproliferationsstorungen | |
| DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
| DE3684409D1 (de) | Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose. | |
| DE69736441D1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| ATE123943T1 (de) | Mittel zur behandlung und vorbeugung von bauchentzündungen, die als wirkstoff zink-l- carnosin-salze oder -komplexe enthalten. | |
| HK1004257A1 (en) | Use of droloxifene in the treatment of bone diseases | |
| DE69422450D1 (de) | Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
| ATE170077T1 (de) | Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'- halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff | |
| GR3026369T3 (en) | Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist. | |
| ATE141505T1 (de) | Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht | |
| ATE181329T1 (de) | Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung | |
| ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
| DE69521536T2 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
| DE69327328D1 (de) | Verwendund von norastemizol zur behandlung der allergischen rhinitis | |
| DK0696283T3 (da) | 2-, 3,- 4,- 5,- 6,- 7,- 8,- 9,- og/eller 10 substituerede dibenzoxazepinforbindelser, lægemidler og anvendelser | |
| DE69029693D1 (de) | Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz | |
| KR890003390A (ko) | 골다공증 및 관련된 장해의 치료방법 | |
| DE69733169D1 (de) | Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs | |
| ATE193450T1 (de) | Pharmazeutische zusammensetzung zur vorbeugung oder behandlung von knochenbrüchen | |
| DE69528068D1 (de) | Conagenine zur prävention und behandlung von diarrhöe | |
| ATE245421T1 (de) | Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten | |
| ATE316373T1 (de) | Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn |